XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors

Clinical trial NCT07688577 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07688577
Sponsor: Xilio Development, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic NSCLC - Non-Small Cell Lung Cancer Advanced Solid Tumor

Start date: 2026-08-01
Primary completion: 2029-11-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.